Atlanta, GA - According to a Reg D filing with the U.S. Securities and Exchange Commission, Atlanta-based CardioMems Inc. has raised $22.1 million out of a $29.5 million offering. (more…)

Durham, NC - Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced the closing of its previously announced public offering of 22,222,223 shares of its common stock. The Company also announced that the underwriter exercised in full its over-allotment option to purchase an additional 3,333,332 shares, bringing the total shares sold to 25,555,555 at a price of $4.50 per share for gross proceeds of $115 million. (more…)

Research Triangle Park, NC - Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, today announced the completion of a $16.1 million Series E financing. Leading life science venture capital investors Canaan Partners, Alta Partners, Sanderling Ventures and Asset Management Company participated in this insider round. (more…)

Nashville, TN - Cumberland Pharmaceuticals Inc. announced today the pricing of its initial public offering of 5,000,000 shares of the Company’s common stock at a price to the public of $17.00 per share, raising $85.0 million in gross proceeds before deducting underwriting discounts and commissions as well as offering expenses. In addition, the Company has granted the underwriters a 30-day option (more…)

Raleigh, NC - Micell Technologies Inc., a biomedical device company developing drug eluding stents, has raised $5 million from insiders and is considering a larger round, according to DowJones’ VentureWire. (more…)